Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $208000.0.

  • Viemed Healthcare's Gains from Investment Securities fell 9192.23% to $208000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 1351.27%. This contributed to the annual value of $6.8 million for FY2024, which is 9144.7% up from last year.
  • Latest data reveals that Viemed Healthcare reported Gains from Investment Securities of $208000.0 as of Q3 2025, which was down 9192.23% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Viemed Healthcare's Gains from Investment Securities peaked at $4.1 million during Q2 2025, and registered a low of -$1.4 million during Q1 2022.
  • For the 5-year period, Viemed Healthcare's Gains from Investment Securities averaged around $1.2 million, with its median value being $505000.0 (2023).
  • In the last 5 years, Viemed Healthcare's Gains from Investment Securities skyrocketed by 1802500.0% in 2021 and then plummeted by 19888.42% in 2022.
  • Quarter analysis of 5 years shows Viemed Healthcare's Gains from Investment Securities stood at $8000.0 in 2021, then plummeted by 17825.0% to -$1.4 million in 2022, then surged by 124.54% to $348000.0 in 2023, then increased by 18.1% to $411000.0 in 2024, then crashed by 49.39% to $208000.0 in 2025.
  • Its last three reported values are $208000.0 in Q3 2025, $4.1 million for Q2 2025, and $3.0 million during Q1 2025.